Unmet needs among people reported with hepatitis C, New York City

Journal of Public Health Management and Practice

Volumn 17, Issue 4, 2011, Pages

  Bornschlegel, Katherine ^a   Crotty, Kelly J ^a,b   Sahl, Sara ^a   Balter, Sharon ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

education; hepatitis C; New York City; secondary prevention; support group; surveillance; unmet needs

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; COUNSELING; DISEASE COURSE; DRINKING BEHAVIOR; FEMALE; HEALTH SERVICE; HEALTH STATUS; HEALTH SURVEY; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; NEEDS ASSESSMENT; SELF HELP; UNITED STATES;

ADOLESCENT; ADULT; AGED; ALCOHOL DRINKING; COUNSELING; DISEASE PROGRESSION; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HEALTH STATUS; HEPATITIS A VACCINES; HEPATITIS B VACCINES; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; NEEDS ASSESSMENT; NEW YORK CITY; POPULATION SURVEILLANCE; SELF-HELP GROUPS; YOUNG ADULT;

EID: 79958865084     PISSN: 10784659     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHH.0b013e3182053f1b     Document Type: Article

References (29)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705-714.
2. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13(17):2436-2441. (Pubitemid 46929498)
3. Wasley A, Grytdal S, Gallagher K. Surveillance for acute viral hepatitis - United States, 2006. MMWR Surveill Summ. 2008;57(2):1-24.
4. Bornschlegel K, Berger M, Garg RK, et al. Prevalence of Hepatitis C infection in New York City, 2004. J Urban Health. 2009;86(6):909-917.
5. Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ. 2009;58(3):1-27.
6. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 1997; 349(9055):825-832. (Pubitemid 27129209)
7. Institute of Medicine. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Washington, DC: Institute of Medicine; 2010.
8. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49(4):1335-1374.
9. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004;39(4):1147-1171. (Pubitemid 38428955)
10. Miller ER, Hiller JE, Shaw DR. Quality of life in HCV-infection: lack of association with ALT levels. Aust NZJ Public Health. 2001;25(4):355-361. (Pubitemid 32791531)
11. Jessop AB, Cohen C, Burke MM, Conti M, Black M. Hepatitis support groups: meeting the information and support needs of hepatitis patients. Gastroenterol Nurs. 2004;27(4):163-169.
12. Grebely J, Genoway K, Khara M, et al. Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection. Int J Drug Policy. 2007;18(5):437-443. (Pubitemid 47381422)
13. Public Health - Seattle and King County. June 2005, Vol. 45, No. 6: Survey of hepatitis C patient needs. http://www.kingcounty.gov/healthServices/ health/communicable/epilog/2005.aspx. Accessed November 20, 2009.
14. Centers for Disease Control and Prevention. Signal-to-cut-off ratios for commercially available assays (hepatitis C). http://www.cdc.gov/hepatitis/HCV/ LabTesting.htm#section1. Accessed November 20, 2009.
15. New York City Department of Health and Mental Hygiene. Hepatitis A, B and C surveillance report. http://www.nyc.gov/html/doh/downloads/pdf/cd/cd- hepabcsurveillance-report-06-07.pdf. Accessed November 20, 2009.
16. Marcellin P, Pequignot F, Delarocque-Astagneau E, et al. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J Hepatol. 2008;48(2):200-207.
17. Westin J, Lagging LM, Spak F, et al. Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepat. 2002;9(3):235-241. (Pubitemid 36005523)
18. Harris DR, Gonin R, Alter HJ, et al. The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Ann Intern Med. 2001;134(2):120-124. (Pubitemid 32096339)
19. Delarocque-Astagneau E, Roudot-Thoraval F, Campese C, Desenclos JC, The Hepatitis CSSSC. Past excessive alcohol consumption: a major determinant of severe liver disease among newly referred hepatitis C virus infected patients in hepatology reference centers, France, 2001. Ann Epidemiol. 2005;15(8):551-557.
20. Blixen CE, Webster NJ, Hund AJ, et al. Communicating about alcohol consumption to nonharmful drinkers with hepatitis C: patient and provider perspectives. J Gen Intern Med. 2008;23(3):242-247.
21. Fabris P, Tositti G, Giordani MT, et al. Assessing patients' understanding of hepatitis C virus infection and its impact on their lifestyle. Aliment Pharmacol Ther. 2006;23(8):1161-1170. (Pubitemid 43779356)
22. Shehab TM, Sonnad SS, Lok AS. Management of hepatitis C patients by primary care clinicians in the USA: results of a national survey. J Viral Hepat. 2001;8(5):377-383. (Pubitemid 34205892)
23. New York City Department of Health and Mental Hygiene. Diagnosing and managing hepatitis C. http://www.nyc.gov/html/doh/downloads/pdf/chi/chi25-3.pdf. Accessed November 20, 2009.
24. New York City Department of Health and Mental Hygiene. Hepatitis C: the facts, a booklet for people with chronic hepatitis C. http://www.nyc.gov/html/ doh/downloads/pdf/cd/cd-hepc-bro.pdf. Accessed November 20, 2009.
25. Nyamathi A, de Castro V, McNeese-Smith D, et al. Alcohol use reduction program in methadone maintained individuals with hepatitis C virus infection. J Addict Dis. 2008;27(4):27-33.
26. Cormier M. The role of hepatitis C support groups. Gastroenterol Nurs. 2005;28(suppl 1):S4-S9.
27. Litwin AH, Soloway I, Gourevitch MN. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities. Clin Infect Dis. 2005;40(suppl 5):S339-S345. (Pubitemid 40490222)
28. Sylvestre DL, Zweben JE. Integrating HCV services for drug users: a model to improve engagement and outcomes. Int J Drug Policy. 2007;18(5):406-410. (Pubitemid 47381423)
29. New York City Department of Health and Mental Hygiene. NYC Viral Hepatitis Support Groups. http://www.nyc.gov/html/doh/html/cd/cdhepc-support. shtml. Accessed November 20, 2009.